Home
Conditions
Invasive Breast Carcinoma

Clinical trial condition

Invasive Breast Carcinoma

Explore clinical trials studying Invasive Breast Carcinoma. Study availability and eligibility vary by location and protocol.

89 public trials 19 recruiting studies

Refine in advanced search Browse all conditions

Invasive Breast Carcinoma trial results

Not Yet Recruiting

Tissue- and Serum-Derived Exosomal microRNAs as Predictors of Neoadjuvant Chemotherapy Response in Breast Cancer

NCT07500129

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial

NCT07191717

Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, +3 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Completed

Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer

NCT01750073

Conditions: Breast Diseases, Breast Neoplasms, Estrogen Receptor Negative, +20 more
Locations: Nebraska Medicine-Bellevue Bellevue, Nebraska, United States

CHI Health Saint Francis Grand Island, Nebraska, United States

Nebraska Medicine-Village Pointe Cancer Center Omaha, Nebraska, United States

University of Nebraska Medical Center Omaha, Nebraska, United States

View Trial Details

Completed

Enzalutamide and Paclitaxel Before Surgery in Treating Patients With Stage I-III Androgen Receptor-Positive Triple-Negative Breast Cancer

NCT02689427

Conditions: Breast Diseases, Breast Neoplasms, Invasive Breast Carcinoma, +16 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

MD Anderson West Houston Houston, Texas, United States

View Trial Details

Completed

Talimogene Laherparepvec in Combination With Neoadjuvant Chemotherapy in Triple Negative Breast Cancer

NCT02779855

Conditions: Adenocarcinoma, Breast Cancer, Breast Diseases, +15 more
Locations: H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States

View Trial Details

Completed

Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer

NCT02860000

Conditions: Breast Diseases, Breast Neoplasms, Estrogen Receptor Status, +12 more
Locations: Georgetown University Medical Center Washington D.C., District of Columbia, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

University of Michigan Ann Arbor, Michigan, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Nab-Paclitaxel and Atezolizumab Before Surgery in Treating Patients With Triple Negative Breast Cancer

NCT02530489

Conditions: Breast Adenocarcinoma, Breast Diseases, Breast Neoplasms, +7 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer

NCT04481113

Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, +24 more
Locations: OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Completed

Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer

NCT03345420

Conditions: Adenocarcinoma, Breast Carcinoma In Situ, Breast Diseases, +20 more
Locations: Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States

View Trial Details

Completed

Contrast-Enhanced Mammography for Breast Cancer Staging in Patients Referred for a Second Opinion

NCT05036083

Conditions: Breast Carcinoma, Breast Diseases, Breast Neoplasms, +5 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Invasive Breast Carcinoma

Invasive Breast Carcinoma trial results

Related conditions